Navigation Links
SkinMedica Launches TNS Essential Serum(TM)
Date:11/6/2008

-Combines TNS Recovery Complex(R) and APS Corrective Complex(TM)- -97% of Clinical Study Participants Saw Improvements in Skin Elasticity-

CARLSBAD, Calif., Nov. 6 /PRNewswire/ -- SkinMedica, Inc., today announced the recent launch of TNS Essential Serum(TM) a revolutionary anti-aging treatment with a clinically-proven combination of two cutting-edge treatments, TNS Recovery Complex(R) and APS Corrective Complex(TM).

(Photo: http://www.newscom.com/cgi-bin/prnh/20081106/LATH037)

TNS Recovery Complex has been shown to rejuvenate sun damaged and aging skin. It contains the key active ingredient NouriCel-MD(R), a patented blend of growth factors, soluble collagen, antioxidants and matrix proteins. APS Corrective Complex is a potent mixture of three novel peptides and seven antioxidants and other innovative anti-aging ingredients. Combined in TNS Essential Serum, these two formulas work in synergy to transform and regenerate skin for a more youthful, glowing appearance.

"TNS Essential Serum is an unprecedented combination," stated Richard Fitzpatrick, MD, the founder of SkinMedica. "This formulation marries the potent growth factor serum in TNS Recovery Complex with the protective, antioxidant properties of APS Corrective Complex, providing our customers with comprehensive anti-aging care and protection. SkinMedica continues to deliver on its commitment to physicians and consumers to use leading-edge science to develop the most advanced, professional skin-care products available today."

Statistically Significant Clinical Study Results

In a recent clinical study, 37 women aged 32 - 55 with mild-to-severe wrinkling used TNS Essential Serum twice-daily for three months. Study participants were evaluated monthly, using physician assessments, digital photography and patient self-assessment. 97% saw improvements in the elasticity of their skin and 92% rated their skin as looking healthier and more youthful. In addition, TNS Essential Serum demonstrated statistically significant improvements in the following physician-evaluated clinical endpoints:

-- Textural roughness

-- Fine and coarse wrinkles

-- Skin radiance and elasticity

-- Protection from UV exposure and resulting skin damage

TNS Essential Serum is available exclusively at doctor's offices and medically supervised spas. Visit http://www.skinmedica.com to find a location.

About SkinMedica

SkinMedica is a privately held specialty company marketing both prescription and aesthetic products that improve the appearance of skin and treat dermatologic conditions and diseases. SkinMedica's Desonate(R) (desonide) Gel 0.05% is indicated for the treatment of mild-to-moderate atopic dermatitis; EpiQuin(R) Micro (4% hydroquinone) cream is indicated for melasma and postinflammatory hyperpigmentation; VANIQA(R) (eflornithine hydrochloride) Cream, 13.9%, is the only FDA-approved prescription product for the treatment of unwanted facial hair in women; and NeoBenz(R) Micro Cream and NeoBenz(R) Micro SD (single dose) are the only benzoyl peroxide prescription products that contain a patented gradual-release formulation of benzoyl peroxide to treat acne. The company's full line of clinical skin care products, which is sold through physicians, includes TNS Recovery Complex(R) with NouriCel-MD(R) to help improve the health and appearance of aging skin. SkinMedica is based in Carlsbad, California. For more information, visit http://www.skinmedica.com.

SkinMedica(R), Desonate(R), EpiQuin(R) Micro, NeoBenz(R) Micro, NouriCel-MD(R), TNS Recovery Complex(R), and VANIQA(R) are registered trademarks of SkinMedica, Inc.

CONTACT INFORMATION:

Erin McNally

Shop PR

(212) 829-1111 x192

erin@shop-pr.com

http://www.skinmedica.com


'/>"/>
SOURCE SkinMedica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Genesis Pharmaceuticals Launches New Corporate Website
2. Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent
3. HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City
4. Mattel Childrens Hospital UCLA launches program in nanopediatrics
5. DNA2.0 Launches New Website: Enhanced Design and Free Bioinformatics Tools Demonstrate DNA2.0's Customer Focus
6. WeissComm Launches Invigorate Communications to Help Companies Build Successful Health-Based Brands
7. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
8. MRI Expands Energy Role: Launches Center for Integrated Algal Research and Creates Director of Energy Programs Position
9. Finesse Solutions Launches TruBio 3.4 Bioreactor Control Software
10. Finesse Solutions Launches Improved E-Store for Sensors and Transmitters
11. Allied Healthcare Launches First of Line of Ventilators Designed to Meet Demands of Mass Casualty Incidents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... Springs, FL (PRWEB) , ... August 17, 2017 ... ... announced that the stock market news outlet had provided a research update on ... company's nasally administered TRT product. , According to Soulstring, prescription rates for Natesto® ...
(Date:8/16/2017)... Yorba Linda, Ca (PRWEB) , ... August 16, ... ... resist treatment by changing into a different cell type. Many treatments for specific ... tissue. A prominent example of targeted treatment is androgen deprivation therapy for advanced ...
(Date:8/16/2017)... 16, 2017  This year,s edition of the Inc. 5000 features a ... workforce solutions, has made the list for the third year in a ... fastest-growing private companies based on a set of quantitative metrics. In addition, ... fastest-growing companies in the Bay State . ... Inc. 5000 ...
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... ... graphene biosensors that accelerate pharmaceutical and biotherapeutics development, announces the launch of the ... of steps needed to gain kinetic binding data for a wide range of ...
Breaking Biology Technology:
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and ... 2022", published by MarketsandMarkets, the market is expected to be worth USD 18.98 ... Continue Reading ... ...      ...
Breaking Biology News(10 mins):